Neurodegenerative Disease Treatments

Posted by Tracy Hendershott on Jan 14, 2019 9:00:00 AM

While we have numerous symptomatic treatments today, there is still no cure for neurodegenerative diseases such as Parkinson’s and Alzheimer’s. There are more than 600 neurodegenerative diseases alone that affect the brain, spine, and peripheral nervous system. While diseases like Parkinson’s affect motor functions, Alzheimer’s is a progressive disease that destroys memory and other mental functions.

Read More

Tags: BioPharma, Central Laboratory, Parkinson's Disease, Alzheimer's Disease, Neurodegenerative

Eurofins Central Laboratory Celebrates 30 Years of GLP

Posted by Sandra Hageman on Jan 7, 2019 9:00:00 AM

 

Celebrating Thirty Years of Good Laboratory Practice

The GLP (Good Laboratory Practice) Testing Facility of Eurofins Central Laboratory in Breda, The Netherlands has been accredited for OECD GLP for over 30 years. It all started at the BCO Centre for Research (B for Bergschot 71, the street address ever since) with the first inspection by the Dutch Health Care Inspectorate in June 1988. Over the years, BCO underwent several transformations and evolved into becoming one of the Eurofins Central Laboratory facilities, keeping the GLP Test Facility embedded in the Breda Clinical Laboratory.

Read More

Tags: Bioanalytical Testing, BioPharma, Central Laboratory, Quality, Results

Cervical Health Awareness Month

Posted by Jesse Gehris on Jan 3, 2019 2:00:00 PM

Throughout the month, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, stands with the American Cancer Society to recognize January as Cervical Cancer Awareness Month. According to the World Health Organization (WHO):

Read More

Tags: Bioanalytical Testing, Development, Clinical Trial, Central Laboratory, Cervical Cancer

FDA Approves New Treatment for Adult Patients With Rare, Life-Threatening Blood Disease (PNH)

Posted by Tracy Hendershott on Dec 24, 2018 9:00:00 AM

At Eurofins BioPharma Services, we feel this FDA press release, as a Christmas gift that came early! After working on multiple protocols, across multiple clients, we couldn't be happier to see the continued evolution of treatment solutions for this rare disease (around 2 cases per million). Prior to the first treatment being released in 2007, life expectancy of patient diagnosed with PNH was only ten years, with poor quality of life throughout that time. With the significant resource dedication of years of effort and capital, our peers and colleagues throughout the clinical trial industry have allowed patients to have:

Read More

Tags: FDA, Central Laboratory, Clinical Trial, PNH, New Treatment

FDA Guidance: Testicular Toxicity

Posted by Tracy Hendershott on Nov 26, 2018 9:29:00 AM

 

Testicular Toxicity

After being in the draft stages for approximately three years and continuing to receive industry feedback, the FDA CDER has just released final Guidance for Industry Title Testicular Toxicity: Evaluation During Drug Development in October 2018. There are numerous challenges with conducting multi-center clinical trials focusing on testicular toxicity and yet remaining within the realm of guidance from the FDA per their statement:

Read More

Tags: FDA, Testicular Toxicity, Central Laboratory, Clinical Trial

World COPD Day

Posted by Tracy Hendershott on Nov 21, 2018 9:00:00 AM

World Chronic Obstructive Pulmonary Disease (COPD) Day is organized by the Gloobal Initiative for Chronic Obstructive Lung Disease (GOLD) in collaboration with health care professionals and COPD patient groups throughout the world. World COPD Day is celebrated on November 15th, 2018, and it's aim is to raise awareness about the disease and improve outcomes throughout the world.

Read More

Tags: Clinical Trial, Drug Development, Central Laboratory

World Prematurity Day

Posted by Tracy Hendershott on Nov 16, 2018 9:00:00 AM

On November 17th, 2018, we celebrate World Prematurity Day with March of Dimes. According to March of Dimes, "Premature birth is the leading cause of death in children under the age of five worldwide. Babies born too early may have more health issues than babies born on time, and may face long-term health problems that affect the brain, the lungs, hearing or vision."

Read More

Tags: Prematurity, BioPharma, Central Laboratory

World Diabetes Day

Posted by Tracy Hendershott on Nov 14, 2018 9:00:00 AM

On November 14th, 2018, we celebrate World Diabetes Day (WDD) in remembrance of Sir Frederick Banting, who co-discovered insulin, along with Charles Best in 1922. According to the International Diabetes Federation (IDF), World Diabetes Day was created in 1991 IDF and the World Health Organization in response to increasing concerns about the escalating health threat posed by diabetes to a growing number of people. 

Read More

Tags: Clinical Trial, Central Laboratory, Diabetes

World Quality Day

Posted by Tracy Hendershott on Nov 8, 2018 3:00:00 PM

On Thursday, November 8th, 2018, we celebrate World Quality Day. This day was designed to increase worldwide awareness of the important contribution that quality makes toward both organizational and national growth as well as prosperity.

Read More

Tags: Quality, Central Laboratory, Results, Clinical Trial